fenspiride has been researched along with Airflow Obstruction, Chronic in 7 studies
fenspiride: was heading 1975-94 (see under SPIRO COMPOUNDS 1975-90); use SPIRO COMPOUNDS to search FENSPIRIDE 1975-94; bronchodilator agent used in asthma
Excerpt | Relevance | Reference |
---|---|---|
"PATHOPHYSIOLOGY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): Chronic inflammation of the upper airways, pulmonary parenchyma and pulmonary vasculature is the characteristic feature of COPD." | 5.31 | [Bronchial inflammation during chronic bronchitis, importance of fenspiride]. ( Melloni, B, 2002) |
"The drug was studied on 24 COPD patients." | 2.73 | [The effectiveness of fenspiride in the treatment of patients with chronic obstructive pulmonary disease]. ( Butorov, SI; Muntianu, VI, 2007) |
"To study effects of long-term administration of fenspiride in combination with broncholytic drugs on dynamics of clinical symptoms, external respiration function and quality of life in patients with chronic obstructive pulmonary disease (COPD)." | 2.73 | [Clinicofunctional condition and quality of life in patients with chronic obstructive pulmonary disease before and after outpatient treatment with fenspiride]. ( Bodrug, NI; Butorov, IV; Butorov, SI; Krushka, SI; Tofan, EF, 2008) |
"Clinical signs and symptoms of COPD were evaluated every 2 months (aggregated numerical index of signs and symptoms), as were lung function tests (forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], FEV1/FVC) and a 6-minute walking test." | 2.72 | Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease. ( Kunicina, YL; Shmelev, EI, 2006) |
"PATHOPHYSIOLOGY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): Chronic inflammation of the upper airways, pulmonary parenchyma and pulmonary vasculature is the characteristic feature of COPD." | 1.31 | [Bronchial inflammation during chronic bronchitis, importance of fenspiride]. ( Melloni, B, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuzubova, NA | 2 |
Lebedeva, ES | 2 |
Fedin, AN | 2 |
Dvorakovskaya, IV | 2 |
Titova, ON | 2 |
Preobrazhenskaya, TN | 1 |
Melloni, B | 1 |
Fedorova, TA | 1 |
Ekkert, NV | 1 |
Chernekhovskaia, NE | 1 |
Roĭtman, AP | 1 |
Makarova, OV | 1 |
Zhidkova, NV | 1 |
Shmelev, EI | 1 |
Kunicina, YL | 1 |
Butorov, SI | 2 |
Muntianu, VI | 1 |
Butorov, IV | 1 |
Bodrug, NI | 1 |
Krushka, SI | 1 |
Tofan, EF | 1 |
3 trials available for fenspiride and Airflow Obstruction, Chronic
Article | Year |
---|---|
Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Beclomethasone; Drug Therapy, Combination; Female; Forced Exp | 2006 |
[The effectiveness of fenspiride in the treatment of patients with chronic obstructive pulmonary disease].
Topics: Adult; Aged; Ambulatory Care; Anti-Inflammatory Agents; Bronchodilator Agents; Female; Humans; Male; | 2007 |
[Clinicofunctional condition and quality of life in patients with chronic obstructive pulmonary disease before and after outpatient treatment with fenspiride].
Topics: Adult; Ambulatory Care; Anti-Asthmatic Agents; Bronchodilator Agents; Exercise Tolerance; Female; Hu | 2008 |
4 other studies available for fenspiride and Airflow Obstruction, Chronic
Article | Year |
---|---|
Protective effect of fenspiride on the bronchi in rats with chronic obstructive pulmonary disease.
Topics: Animals; Bronchi; Bronchodilator Agents; Capsaicin; Inflammation; Male; Muscle Contraction; Muscle, | 2013 |
Effect of fenspiride on bronchial smooth muscle of rats with chronic obstructive pulmonary disease.
Topics: Animals; Bronchi; Bronchodilator Agents; Disease Models, Animal; Dose-Response Relationship, Drug; I | 2013 |
[Bronchial inflammation during chronic bronchitis, importance of fenspiride].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchitis, Chronic; Bronchoconstriction; Clinical | 2002 |
[Potential of antiinflammatory therapy in patients with chronic obstructive lung disease].
Topics: Adult; Aged; Antimicrobial Cationic Peptides; Blood Proteins; Bronchoscopy; C-Reactive Protein; Fema | 2005 |